M. N. V. Ravi Kumar

13.4k total citations · 5 hit papers
114 papers, 10.7k citations indexed

About

M. N. V. Ravi Kumar is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, M. N. V. Ravi Kumar has authored 114 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pharmaceutical Science, 35 papers in Molecular Biology and 34 papers in Biomaterials. Recurrent topics in M. N. V. Ravi Kumar's work include Advanced Drug Delivery Systems (37 papers), Nanoparticle-Based Drug Delivery (24 papers) and RNA Interference and Gene Delivery (13 papers). M. N. V. Ravi Kumar is often cited by papers focused on Advanced Drug Delivery Systems (37 papers), Nanoparticle-Based Drug Delivery (24 papers) and RNA Interference and Gene Delivery (13 papers). M. N. V. Ravi Kumar collaborates with scholars based in United States, India and United Kingdom. M. N. V. Ravi Kumar's co-authors include V. Bhardwaj, Abraham J. Domb, Corrado Muzzarelli, Riccardo A.A. Müzzarelli, Hitoshi Sashiwa, D. D. Ankola, S. Hariharan, Indu Bala, Udo Bakowsky and Meenakshi Arora and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and ACS Nano.

In The Last Decade

M. N. V. Ravi Kumar

112 papers receiving 10.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chitosan Chemistry and Pharmaceutical Perspectives

2004 2.4k citations M. N. V. Ravi Kumar et al. profile →
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer

2009 786 citations M. N. V. Ravi Kumar et al. profile →
Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective

2006 671 citations M. N. V. Ravi Kumar et al. profile →
PLGA Nanoparticles in Drug Delivery: The State of the Art;

2004 570 citations M. N. V. Ravi Kumar et al. profile →
Poly(lactic acid) blends in biomedical applications

2016 422 citations Prabhjot K. Saini, Meenakshi Arora et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. N. V. Ravi Kumar United States	45	4.4k	3.1k	2.4k	1.7k	1.5k	114	10.7k
Fwu‐Long Mi Taiwan	65	5.6k 1.3×	2.8k 0.9×	2.0k 0.8×	2.8k 1.7×	1.9k 1.3×	155	12.3k
Viness Pillay South Africa	55	3.7k 0.8×	3.2k 1.0×	2.0k 0.8×	3.2k 1.9×	1.3k 0.9×	303	11.6k
Christine Vauthier France	51	3.9k 0.9×	2.8k 0.9×	2.2k 0.9×	1.8k 1.1×	525 0.4×	143	8.4k
Alejandro Sosnik Israel	47	2.8k 0.6×	2.5k 0.8×	1.7k 0.7×	1.6k 0.9×	881 0.6×	181	8.0k
Yahya E. Choonara South Africa	53	3.7k 0.8×	2.6k 0.8×	2.0k 0.8×	3.3k 1.9×	1.1k 0.7×	384	11.1k
Kevin J. Edgar United States	47	3.4k 0.8×	2.3k 0.8×	1.4k 0.6×	1.7k 1.0×	1.1k 0.7×	160	8.6k
Ángel Concheiro Spain	62	4.4k 1.0×	4.1k 1.4×	1.9k 0.8×	3.7k 2.2×	2.0k 1.4×	337	13.9k
Vitaliy V. Khutoryanskiy United Kingdom	55	3.7k 0.8×	4.2k 1.4×	2.0k 0.8×	2.2k 1.3×	2.4k 1.6×	249	12.9k
Lee Yong Lim Australia	49	3.4k 0.8×	1.9k 0.6×	2.5k 1.0×	1.5k 0.9×	691 0.5×	182	9.1k
Qineng Ping China	49	3.5k 0.8×	2.8k 0.9×	3.1k 1.3×	2.0k 1.2×	685 0.5×	213	8.7k

Countries citing papers authored by M. N. V. Ravi Kumar

Since Specialization

Citations

This map shows the geographic impact of M. N. V. Ravi Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. N. V. Ravi Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. N. V. Ravi Kumar more than expected).

Fields of papers citing papers by M. N. V. Ravi Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. N. V. Ravi Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. N. V. Ravi Kumar. The network helps show where M. N. V. Ravi Kumar may publish in the future.

Co-authorship network of co-authors of M. N. V. Ravi Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of M. N. V. Ravi Kumar. A scholar is included among the top collaborators of M. N. V. Ravi Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. N. V. Ravi Kumar. M. N. V. Ravi Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ganugula, Raghu, et al.. (2025). Design and In Vitro Evaluation of Gambogic Acid-Conjugated Stearic Acid Solid Lipid Nanoparticles for Transferrin Receptor-Mediated Drug Delivery. Pharmaceutical Research. 42(12). 2235–2245.

Harwood, Janet, et al.. (2025). Urolithin A-laden functional nanoparticles alleviate cisplatin-induced cardiotoxicity in mice by inhibiting inflammation-induced lymphangiogenesis. Free Radical Biology and Medicine. 237. 491–502. 1 indexed citations

Ganugula, Raghu, et al.. (2025). Dual-function polyester nanoparticles for amplified anti-inflammatory effects. Science Advances. 11(32). eadw1358–eadw1358. 2 indexed citations

Ganugula, Raghu, et al.. (2024). Engineered urolithin A-laden functional polymer-lipid hybrid nanoparticles prevent cisplatin-induced proximal tubular injury in vitro. European Journal of Pharmaceutics and Biopharmaceutics. 200. 114334–114334. 6 indexed citations

Mumba, Mercy Ngosa, et al.. (2024). Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction. ACS Pharmacology & Translational Science. 7(8). 2237–2250. 1 indexed citations

Yang, Wanbao, Meenakshi Arora, Wen G. Jiang, et al.. (2024). ZnPP‐laden nanoparticles improve glucose homeostasis and chronic inflammation during obesity. British Journal of Pharmacology. 181(16). 2886–2904.

Arora, Meenakshi, et al.. (2024). Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies. Pharmacological Reviews. 77(1). 100003–100003. 4 indexed citations

Uppada, Srijayaprakash, Erin M. Scott, Gladys Y.‐P. Ko, et al.. (2022). Paclitaxel and Urolithin A Prevent Histamine-Induced Neurovascular Breakdown Alike, in an Ex Vivo Rat Eye Model. ACS Chemical Neuroscience. 13(14). 2092–2098. 1 indexed citations

Agarwal, Anupam, et al.. (2022). Nano-encapsulation strategies to circumvent drug-induced kidney injury and targeted nanomedicines to treat kidney diseases. Current Opinion in Toxicology. 31. 100346–100346. 3 indexed citations

10.

Arora, Meenakshi, et al.. (2020). Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice. ACS Chemical Neuroscience. 11(13). 1955–1964. 12 indexed citations

11.

Ganugula, Raghu, Meenakshi Arora, Bani K. Mallick, et al.. (2020). Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation. Science Advances. 6(35). eabb7878–eabb7878. 24 indexed citations

12.

Kaur, Ginpreet, Meenakshi Arora, Raghu Ganugula, & M. N. V. Ravi Kumar. (2019). Double-headed nanosystems for oral drug delivery. Chemical Communications. 55(33). 4761–4764. 9 indexed citations

13.

Arora, Meenakshi, et al.. (2019). Low-Dose Curcumin Nanoparticles Normalise Blood Pressure in Male Wistar Rats with Diet-Induced Metabolic Syndrome. Nutrients. 11(7). 1542–1542. 29 indexed citations

14.

Ganugula, Raghu, Meenakshi Arora, & M. N. V. Ravi Kumar. (2017). Ex Vivo Rat Eye Model for Investigating Transport of Next Generation Precision-Polyester Nanosystems. ACS Applied Materials & Interfaces. 9(31). 25668–25671. 3 indexed citations

15.

Ganugula, Raghu, et al.. (2017). Noncompetitive Active Transport Exploiting Intestinal Transferrin Receptors for Oral Delivery of Proteins by Tunable Nanoplatform. ACS Macro Letters. 6(2). 161–164. 18 indexed citations

16.

Ganugula, Raghu, et al.. (2017). Next Generation Precision-Polyesters Enabling Optimization of Ligand–Receptor Stoichiometry for Modular Drug Delivery. Journal of the American Chemical Society. 139(21). 7203–7216. 26 indexed citations

17.

Saini, Prabhjot K., Raghu Ganugula, Meenakshi Arora, & M. N. V. Ravi Kumar. (2016). The Next Generation Non-competitive Active Polyester Nanosystems for Transferrin Receptor-mediated Peroral Transport Utilizing Gambogic Acid as a Ligand. Scientific Reports. 6(1). 29501–29501. 25 indexed citations

18.

Kamaluddin, Kamaluddin, et al.. (2000). Conversion of anilines to their oligomers by copper hexacyanoferrate(II). Indian Journal of Chemical Technology. 7(5). 230–235. 2 indexed citations

19.

Dutta, Pradip Kumar & M. N. V. Ravi Kumar. (1999). Chitosan-amine oxide: Thermal behaviour of the new gelling system. Indian Journal of Chemical Technology. 6(1). 55–56. 7 indexed citations

20.

Kumar, M. N. V. Ravi, et al.. (1998). TRENDS IN COLOR REMOVAL FROM TEXTILE MILL EFFLUENTS. 40(8). 25–34. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact